Dimiracetam structure
|
Common Name | Dimiracetam | ||
|---|---|---|---|---|
| CAS Number | 126100-97-8 | Molecular Weight | 140.14 | |
| Density | 1.4g/cm3 | Boiling Point | 460.5ºC at 760 mmHg | |
| Molecular Formula | C6H8N2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 232.3ºC | |
Use of DimiracetamDimiracetam is an orally active compound, with anti-neuropathic activity. Dimiracetam inhibits hypersensitivity and neurological alterations, and inhibits Sorafenib (HY-10201)-induced neuropathy in cold stimulation rat models[1]. |
| Name | 3,6,7,7a-tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Dimiracetam is an orally active compound, with anti-neuropathic activity. Dimiracetam inhibits hypersensitivity and neurological alterations, and inhibits Sorafenib (HY-10201)-induced neuropathy in cold stimulation rat models[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4g/cm3 |
|---|---|
| Boiling Point | 460.5ºC at 760 mmHg |
| Molecular Formula | C6H8N2O2 |
| Molecular Weight | 140.14 |
| Flash Point | 232.3ºC |
| Exact Mass | 140.05900 |
| PSA | 52.90000 |
| Vapour Pressure | 1.16E-08mmHg at 25°C |
| Index of Refraction | 1.585 |
| InChIKey | XTXXOHPHLNROBN-UHFFFAOYSA-N |
| SMILES | O=C1CN2C(=O)CCC2N1 |
|
~82%
Dimiracetam CAS#:126100-97-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 36, # 26 p. 4214 - 4220 |
|
~22%
Dimiracetam CAS#:126100-97-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 36, # 26 p. 4214 - 4220 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole |
| tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione |
| dimiracetam |
| 1H-Pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione,dihydro |
| (+-)-Dihydro-1H-pyrrolo(1,2-a)imidazole-2,5(3H,6H)-dione |
| Dimiracetam [INN] |